Chemoinformaics analysis of 4-(2-(Dimethylamino)ethyl)-2-methoxyphenol
| Molecular Weight | 195.262 | nRot | 4 |
| Heavy Atom Molecular Weight | 178.126 | nRig | 6 |
| Exact Molecular Weight | 195.126 | nRing | 1 |
| Solubility: LogS | -0.561 | nHRing | 0 |
| Solubility: LogP | 1.22 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 17 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 32.4095 |
| nHD | 1 | BPOL | 20.5005 |
| QED | 0.79 |
| Synth | 1.781 |
| Natural Product Likeliness | 0.333 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.169 |
| HIA | 0.007 |
| CACO-2 | -4.461 |
| MDCK | 0.00000967 |
| BBB | 0.995 |
| PPB | 0.311631 |
| VDSS | 2.187 |
| FU | 0.679821 |
| CYP1A2-inh | 0.052 |
| CYP1A2-sub | 0.938 |
| CYP2c19-inh | 0.023 |
| CYP2c19-sub | 0.948 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.656 |
| CYP2d6-inh | 0.316 |
| CYP2d6-sub | 0.934 |
| CYP3a4-inh | 0.005 |
| CYP3a4-sub | 0.338 |
| CL | 11.711 |
| T12 | 0.859 |
| hERG | 0.115 |
| Ames | 0.013 |
| ROA | 0.823 |
| SkinSen | 0.893 |
| Carcinogencity | 0.189 |
| EI | 0.124 |
| Respiratory | 0.971 |
| NR-Aromatase | 0.011 |
| Antiviral | No |
| Prediction | 0.716992 |